|
Name |
(2R,3S,4aS,7R,8R,8aS)-2,3,4'-trihydroxy-7'-(2-hydroxyethyl)-4,4,7,8a-tetramethylspiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2'-3,8-dihydrofuro[2,3-e]isoindole]-6'-one
|
Molecular Formula | C25H35NO6 | |
IUPAC Name* |
(2R,3S,4aS,7R,8R,8aS)-2,3,4'-trihydroxy-7'-(2-hydroxyethyl)-4,4,7,8a-tetramethylspiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2'-3,8-dihydrofuro[2,3-e]isoindole]-6'-one
|
|
SMILES |
C[C@@H]1CC[C@@H]2[C@@]([C@@]13CC4=C(C=C5C(=C4O3)CN(C5=O)CCO)O)(C[C@H]([C@H](C2(C)C)O)O)C
|
|
InChI |
InChI=1S/C25H35NO6/c1-13-5-6-19-23(2,3)21(30)18(29)11-24(19,4)25(13)10-15-17(28)9-14-16(20(15)32-25)12-26(7-8-27)22(14)31/h9,13,18-19,21,27-30H,5-8,10-12H2,1-4H3/t13-,18-,19+,21-,24+,25-/m1/s1
|
|
InChIKey |
PAILZINGRRXKCY-RNIWIPBASA-N
|
|
Synonyms |
CHEMBL3104978; F1839-E
|
|
CAS | NA | |
PubChem CID | 10026548 | |
ChEMBL ID | CHEMBL3104978 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 445.5 | ALogp: | 2.3 |
HBD: | 4 | HBA: | 6 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 111.0 | Aromatic Rings: | 5 |
Heavy Atoms: | 32 | QED Weighted: | 0.557 |
Caco-2 Permeability: | -5.318 | MDCK Permeability: | 0.00000686 |
Pgp-inhibitor: | 0.059 | Pgp-substrate: | 0.982 |
Human Intestinal Absorption (HIA): | 0.646 | 20% Bioavailability (F20%): | 0.903 |
30% Bioavailability (F30%): | 0.284 |
Blood-Brain-Barrier Penetration (BBB): | 0.763 | Plasma Protein Binding (PPB): | 79.80% |
Volume Distribution (VD): | 1.639 | Fu: | 22.38% |
CYP1A2-inhibitor: | 0.089 | CYP1A2-substrate: | 0.226 |
CYP2C19-inhibitor: | 0.013 | CYP2C19-substrate: | 0.556 |
CYP2C9-inhibitor: | 0.123 | CYP2C9-substrate: | 0.324 |
CYP2D6-inhibitor: | 0.028 | CYP2D6-substrate: | 0.2 |
CYP3A4-inhibitor: | 0.065 | CYP3A4-substrate: | 0.171 |
Clearance (CL): | 10.146 | Half-life (T1/2): | 0.56 |
hERG Blockers: | 0.056 | Human Hepatotoxicity (H-HT): | 0.271 |
Drug-inuced Liver Injury (DILI): | 0.207 | AMES Toxicity: | 0.494 |
Rat Oral Acute Toxicity: | 0.856 | Maximum Recommended Daily Dose: | 0.942 |
Skin Sensitization: | 0.926 | Carcinogencity: | 0.768 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.085 |
Respiratory Toxicity: | 0.909 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002034 | 0.792 | D0KR5B | 0.264 | ||||
ENC002992 | 0.792 | D0D1SG | 0.264 | ||||
ENC003009 | 0.729 | D04VIS | 0.260 | ||||
ENC001975 | 0.729 | D0D2TN | 0.260 | ||||
ENC003017 | 0.729 | D08PIQ | 0.260 | ||||
ENC002009 | 0.660 | D02JNM | 0.252 | ||||
ENC003012 | 0.660 | D0Y2YP | 0.248 | ||||
ENC003008 | 0.654 | D0CW1P | 0.246 | ||||
ENC003019 | 0.649 | D07DVK | 0.246 | ||||
ENC003259 | 0.582 | D0IT2G | 0.246 |